CDKN1C antibody (AA 34-64) (APC)

Catalog No. ABIN1964202

Product Details anti-CDKN1C Antibody (APC)

Target: CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))

Binding Specificity: AA 34-64

Reactivity: Human, Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CDKN1C antibody is conjugated to APC

Application: Western Blotting (WB), ELISA

Specificity: This CDKN1C antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 34-64 amino acids from the N-terminal region of human CDKN1C.

Purification: Protein A purified

Isotype: IgG

Application Details

Application Notes: Approved: ELISA, WB

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS, no preservatives added

Preservative: Without preservative

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: 4 °C,-20 °C

Storage Comment: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Expiry Date: 6 months

Target Details for CDKN1C

Target: CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))

Alternative Name: CDKN1C / p57 Kip2 (CDKN1C Products)

Synonyms: BWCR antibody, BWS antibody, KIP2 antibody, WBS antibody, p57 antibody, p57Kip2 antibody, cb961 antibody, p27Xic1-a antibody, zgc:86618 antibody, AL024410 antibody, CDKI antibody, Kip2 antibody, p57(kip2) antibody, p57KIP2 antibody, cyclin dependent kinase inhibitor 1C antibody, cyclin-dependent kinase inhibitor 1Ca antibody, cyclin-dependent kinase inhibitor 1C (P57) antibody, cyclin-dependent kinase inhibitor 1C antibody, CDKN1C antibody, cdkn1ca antibody, Cdkn1c antibody

Background: Name/Gene ID: CDKN1C

Synonyms: CDKN1C, BWS, KIP2, IMAGE, p57Kip2, p57, p57 KIP2, Beckwith-Wiedemann syndrome, WBS, BWCR

Gene ID: 1028

Pathways: Cell Division Cycle, Dopaminergic Neurogenesis